Lexicon Pharmaceuticals, Inc. is downgraded to Hold due to repeated FDA rejections of ZYNQUISTA for T1D and catalysts. Read more on LXRX stock here.
High blood pressure and body mass index, or BMI, may be directly linked to the increased risk of developing vascular dementia ...
NEW YORK CITY, NEW YORK / ACCESS Newswire / January 21, 2026 / For decades, luxury operated on an unspoken agreement: ...
How do you get your business to the level where it can be sold? And more importantly, how do you reach that level in today’s ...
President Trump is addressing the gathering of world leaders, CEOs and policymakers as America's allies balk at his efforts ...
Governments can't regulate AI in time. Tech firms are too big to fail. If AI governance happens at all, it will happen in the ...
The "Sell America" trade compelled investors to dump U.S. stocks and bonds, while gold and silver, both safe haven assets, ...
Shares of Vistra (NYSE:VST) are going through a bit of a slump, now down around 24% from its peak. Undoubtedly, the bear ...
The Cboe Volatility Index, often referred to as Wall Street’s “fear gauge,” surged Tuesday and approached a three-month high, ...
BitMine is stacking Ethereum through staking, but a bearish chart threatens a breakdown. One BMNR stock price level decides ...
Philippine stocks remained above the 6,400 level Monday despite heavy profit-taking. The 30-company Philippine Stock Exchange ...
Corning shows margin gains as Optical Communications posts 58% YoY Q3 FY25 sales growth, with high multiples and execution ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback